
    
      In this study, patients with monogenic cardiovascular disease are recruited prospectively
      after informed consent was given. The investigator will collect the baseline clinical
      characteristics of the patients at enrollment, including comprehensive physical examination,
      laboratory testing of blood and urine, electrocardiography, 24-hour Holter, echocardiography,
      MRI and other examinations if necessary. The specimens retained include blood, saliva, urine
      and feces for all patients, and myocardium for patients receive cardio myectomy surgery .
      Genetic testing will be performed to identify novel disease genes, genetic risk factors and
      potential therapy targets.
    
  